272 related articles for article (PubMed ID: 19566834)
21. Development of the procedures for high-yield expression and rapid purification of active recombinant Csk-homologous kinase (CHK): comparison of the catalytic activities of CHK and CSK.
Chan KC; Lio DS; Dobson RC; Jarasrassamee B; Hossain MI; Roslee AK; Ia KK; Perugini MA; Cheng HC
Protein Expr Purif; 2010 Dec; 74(2):139-47. PubMed ID: 20667476
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of human SRC-family kinase substrate specificity in vitro.
Takeda H; Kawamura Y; Miura A; Mori M; Wakamatsu A; Yamamoto J; Isogai T; Matsumoto M; Nakayama KI; Natsume T; Nomura N; Goshima N
J Proteome Res; 2010 Nov; 9(11):5982-93. PubMed ID: 20863140
[TBL] [Abstract][Full Text] [Related]
23. The interplay between Src family kinases and receptor tyrosine kinases.
Bromann PA; Korkaya H; Courtneidge SA
Oncogene; 2004 Oct; 23(48):7957-68. PubMed ID: 15489913
[TBL] [Abstract][Full Text] [Related]
24. The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors.
Alvarez RH; Kantarjian HM; Cortes JE
Cancer; 2006 Oct; 107(8):1918-29. PubMed ID: 16986126
[TBL] [Abstract][Full Text] [Related]
25. Interaction between the SH3 domain of Src family kinases and the proline-rich motif of HTLV-1 p13: a novel mechanism underlying delivery of Src family kinases to mitochondria.
Tibaldi E; Venerando A; Zonta F; Bidoia C; Magrin E; Marin O; Toninello A; Bordin L; Martini V; Pagano MA; Brunati AM
Biochem J; 2011 Nov; 439(3):505-16. PubMed ID: 21732913
[TBL] [Abstract][Full Text] [Related]
26. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the activity of SRC and Abl tyrosine protein kinases by the binding of the Wiskott-Aldrich syndrome protein.
Schulte RJ; Sefton BM
Biochemistry; 2003 Aug; 42(31):9424-30. PubMed ID: 12899629
[TBL] [Abstract][Full Text] [Related]
28. Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer.
Edwards J
Expert Opin Investig Drugs; 2010 May; 19(5):605-14. PubMed ID: 20367532
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-delta with Src family kinases in the RBL-2H3 mast cell line: regulation of Src family kinase activity by protein kinase C-delta.
Song JS; Swann PG; Szallasi Z; Blank U; Blumberg PM; Rivera J
Oncogene; 1998 Jul; 16(26):3357-68. PubMed ID: 9692543
[TBL] [Abstract][Full Text] [Related]
30. Protein tyrosine kinases, with emphasis on the Src family.
Courtneidge SA
Semin Cancer Biol; 1994 Aug; 5(4):239-46. PubMed ID: 7528561
[TBL] [Abstract][Full Text] [Related]
31. Src family kinase potentiates the activity of nicotinic acetylcholine receptor in rat autonomic ganglion innervating urinary bladder.
Kim NH; Park KS; Cha SK; Yoon JH; Yeh BI; Han KH; Kong ID
Neurosci Lett; 2011 May; 494(3):190-5. PubMed ID: 21396981
[TBL] [Abstract][Full Text] [Related]
32. Allosteric Modulation of Src Family Kinases with ATP-Competitive Inhibitors.
Register AC; Chakraborty S; Maly DJ
Methods Mol Biol; 2017; 1636():79-89. PubMed ID: 28730474
[TBL] [Abstract][Full Text] [Related]
33. How ATP-Competitive Inhibitors Allosterically Modulate Tyrosine Kinases That Contain a Src-like Regulatory Architecture.
Fang L; Vilas-Boas J; Chakraborty S; Potter ZE; Register AC; Seeliger MA; Maly DJ
ACS Chem Biol; 2020 Jul; 15(7):2005-2016. PubMed ID: 32479050
[TBL] [Abstract][Full Text] [Related]
34. Novel patented SRC kinase inhibitor.
Lu XL; Liu XY; Cao X; Jiao BH
Curr Med Chem; 2012; 19(12):1821-9. PubMed ID: 22414081
[TBL] [Abstract][Full Text] [Related]
35. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
Goel RK; Lukong KE
Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
[TBL] [Abstract][Full Text] [Related]
36. Defining the substrate specificity determinants recognized by the active site of C-terminal Src kinase-homologous kinase (CHK) and identification of β-synuclein as a potential CHK physiological substrate.
Ia KK; Jeschke GR; Deng Y; Kamaruddin MA; Williamson NA; Scanlon DB; Culvenor JG; Hossain MI; Purcell AW; Liu S; Zhu HJ; Catimel B; Turk BE; Cheng HC
Biochemistry; 2011 Aug; 50(31):6667-77. PubMed ID: 21699177
[TBL] [Abstract][Full Text] [Related]
37. Aberrant regulation and function of Src family tyrosine kinases: their potential contributions to glutamate-induced neurotoxicity.
Hossain MI; Kamaruddin MA; Cheng HC
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):684-91. PubMed ID: 21973029
[TBL] [Abstract][Full Text] [Related]
38. New Structural Perspectives in G Protein-Coupled Receptor-Mediated Src Family Kinase Activation.
Berndt S; Liebscher I
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204297
[TBL] [Abstract][Full Text] [Related]
39. An Update on Src Family of Nonreceptor Tyrosine Kinases Biology.
Espada J; Martín-Pérez J
Int Rev Cell Mol Biol; 2017; 331():83-122. PubMed ID: 28325216
[TBL] [Abstract][Full Text] [Related]
40. [SRC kinases in tumor therapy].
Dempke W; Zippel R
Med Klin (Munich); 2010 Oct; 105(10):711-5. PubMed ID: 20981590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
